Table 3:
Toxicities of Induction Chemotherapy
CTCAE Grade | ||||
---|---|---|---|---|
3 | 4 | 5 | Total | |
Neutropenia | 2 | 3 | 0 | 5 (9%) |
Diarrhea | 4 | 0 | 0 | 4 (7%) |
Nausea | 4 | 0 | 0 | 4 (7%) |
Vomiting | 3 | 0 | 0 | 3 (5%) |
Dehydration | 2 | 0 | 0 | 2 (4%) |
Hypokalemia | 2 | 0 | 0 | 2 (4%) |
Alanine aminotransferase increased | 1 | 0 | 0 | 1 (2%) |
Anemia | 1 | 0 | 0 | 1 (2%) |
Anorexia | 1 | 0 | 0 | 1 (2%) |
Decreased Glomerular Filtration Rate | 0 | 1 | 0 | 1 (2%) |
Hand-and-foot syndrome | 1 | 0 | 0 | 1 (2%) |
Hyponatremia | 1 | 0 | 0 | 1 (2%) |
Pneumonia | 1 | 0 | 0 | 1 (2%) |
Intracranial hemorrhage | 0 | 0 | 1 | 1 (2%) |
Mucositis oral | 1 | 0 | 0 | 1 (2%) |
Pruritus | 1 | 0 | 0 | 1 (2%) |
Rash | 1 | 0 | 0 | 1 (2%) |
Sepsis | 0 | 1 | 0 | 1 (2%) |
Thrombosis/thrombus/embolism | 1 | 0 | 0 | 1 (2%) |
Weight loss | 1 | 0 | 0 | 1 (2%) |
Laryngospasm | 1 | 0 | 0 | 1 (2%) |
Sudden Cardiac Arrest | 0 | 0 | 1 | 1 (2%) |
Includes all grade 3 or greater toxicities seen during induction chemotherapy and assessed by investigator to be possibly, probably, or definitely due to therapy